+91-8668442535
Home / Biotechnology / Western Bl

Western Blotting Market By Product Type (Consumables, Instruments, Imagers), By Application (Biomedical And Biochemical Research, Disease Diagnostics, Agri-Biotech), By Usage Area (Research And Academia, Pharmaceuticals And Biotech, Disease Diagnosis) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Western blotting, or protein immunoblotting, is the technique used for the detection and quantification of specific proteins in a sample. This technique is a major contributor to the molecular diagnostics market. The growing prevalence of HIV worldwide, the increasing range of applications of western blotting, and extensive R&D initiatives being undertaken in this space by biotechnology and pharmaceutical companies are the major drivers of the global western blotting market. On the other hand, threats from alternative detection techniques and the high price of blotting apparatus and devices may hold back the growth of this market. Some of the major trends observed in the global western blotting market are a high investment in research and development, increasing adoption of automation, and the introduction of novel imaging software for efficient blotting and detection, among others.

The purpose of this research study titled "Western Blotting Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global western blotting market. This report presents and analyzes the major trends prevalent in the global western blotting market and the market size and forecast.

This report categorizes the global western blotting market in terms of product type, application, usage areas, and geographical distribution. Based on product type, the global western blotting market is categorized into consumables (reagents and kits), instruments (gel electrophoresis instruments), blotting systems (wet blotting instruments, and semi-dry blotting instruments), and imagers (chemiluminescent imagers, fluorescent imagers, and others). Biomedical and biochemical research, disease diagnostics, agri-biotech, and others are the chief application areas considered for the purpose of this study. On the basis of usage areas, the global Western blotting market is categorized into research and academia, pharmaceuticals and biotech, disease diagnosis, and others. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global western blotting market is best understood by categorizing it into five major regions and five major region-level markets, as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectionally presented in terms of product type, applications, usage areas, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global western blotting market. Competition assessment tools such as major agreements, partnerships, and collaborations, market attractiveness assessment, and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the western blotting market. The key players profiled in this report are Advansta, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Merck KGaA, PerkinElmer, Inc., Sigma-Aldrich Co., Thermo Fisher Scientific, Inc., and Trinity Biotech Plc.

Based on the product types, the global western blotting market is segmented as follows:

  • Consumables
  • Reagents
  • Kits
  • Instruments
  • Gel electrophoresis instruments
  • Blotting Systems
  • Wet Blotting Instruments
  • semi-dry blotting instruments
  • Images
  • Chemiluminescent Imagers
  • Fluorescent Imagers
  • Others

Between consumables and instruments, the consumables segment dominates the global western blotting market. Significant rise in the incidence of target diseases that demand western blotting-based research and diagnosis. Larger purchase and usage volumes of these products thus lead to the dominance of this segment. Additionally, the instruments segment, including gel electrophoresis instruments, blotting systems, and imagers, will be the fastest-growing segment during the forecast period. The rapid adoption of Western blotting techniques in Asia Pacific emerging markets due to an increase in R&D activities and outsourcing will support the growth of the instruments segment. Among the types of instruments, electrophoresis systems will register the fastest growth rate in the market during the forecast period.

Based on the types of applications, the global fluoroscopy systems market is segmented as follows:

  • biomedical and biochemical research
  • Disease Diagnostics
  • Agri-biotech
  • Others

Biochemical and biomedical research is reported to be the largest segment in the global western blotting market in 2016. Increased government funding for proteomics research and personalized medicine, as well as increased R&D expenditure by pharmaceutical and biotechnology companies, are all contributing significantly to this segment's dominance. Additionally, the growing incidence of target infections such as HIV/AIDS, Lyme disease, HBV, and HSV that tout western blotting as the gold standard for diagnosis makes disease diagnostics the fastest-growing application segment during the forecast period. Other diseases that use the western blotting technique for efficient diagnosis include feline immunodeficiency and mad cow disease.

Based on the usage areas, the global western blotting market is segmented as follows:

  • Research and academia
  • Pharmaceuticals and Biotech
  • Disease Diagnosis
  • Others

The research and academia segment accounted for the largest share of the global western blotting market. The dominance of this segment is largely attributed to the significant influx of institutional and government funds into research with a focus on the introduction of breakthrough technologies and exploratory tools in the fields of proteomics and personalized medicine. Additionally, the intention of embarking on a footprint in the market through novel drug discovery and diagnostic tools makes pharmaceuticals and biotech a competitive segment. On the other hand, it is expected that disease diagnosis will be the fastest-progressing segment during the forecast period. Rapidly growing incidences of infections such as Lyme disease, HIV/AIDS, HBV, etc., corresponding to the intent of containing the perpetually growing socioeconomic burden of such diseases, drive the growth of this segment.

Geographically, the global Western blotting market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

At present, North America and Western Europe account for the largest revenue share in the global western blotting market. The domicile of a large number of market incumbents and research institutes in the region evolved research infrastructure, and high awareness majorly contributes to the dominance of North America and Europe. On the other hand, the Asia Pacific market is being driven by an alarming increase in the incidence of target diseases, particularly hepatitis and HIV/AIDS, as well as a growing trend of outsourcing research and development contracts to countries such as India, Malaysia, and others, making it the fastest-growing regional market. The global western blotting market is highly competitive in nature and is characterized by the growing penetration activities of large market players in emerging economies, increasing strategic collaborations, and M&A activities.

The detailed regional classification of the global western blotting market is as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, the U.K., and the Rest of Europe)
  • Asia Pacific (China, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Questions:

The market for Western Blotting Market is expected to reach US$ 872.5 Mn By 2025.

The Western Blotting Market is expected to see significant CAGR growth over the coming years, at 5.1%.

The report is forecasted from 2017-2025.

The base year of this report is 2015.

Advansta, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Merck KGaA, PerkinElmer, Inc are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Aug 2017
Category:  Biotechnology
Report ID:   58630
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support